NCT05534828

Brief Summary

Monocentric, observational, descriptive RIPH3 study with prospective data collection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
97

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 10, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

October 10, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

September 25, 2024

Status Verified

September 1, 2024

Enrollment Period

9 months

First QC Date

September 6, 2022

Last Update Submit

September 23, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence at 3 months of PICS

    Incidence at 3 months of PICS as defined below: A PICS is defined as ''present'' at the 3-month visit if the patient has one or more of the following: * Impaired quality of life as defined by a 5D5L EQ score greater than or equal to 3 on at least 1 dimension of the questionnaire. * Anxiety symptoms defined by a HADS anxiety score greater than or equal to 11. * Depressive symptoms defined by a HADS depression score greater than or equal to 11. * Symptoms of post-traumatic stress defined by a PCL 5 score greater than or equal to 33. * Symptoms of undernutrition defined by an NRS score greater than or equal to 3. * Pain symptoms defined by a DN4 score greater than or equal to 4 and/or an EVS score greater than or equal to 4.

    month 3

Interventions

A consultationDIAGNOSTIC_TEST

A consultation at three months of discharge from the intensive care unit in the population of patients surviving a multivalent intensive care unit stay

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

population of patients surviving a stay in polyvalent resuscitation

You may qualify if:

  • adult patient
  • hospitalized in the intensive care unit of Rangueil of the TOULOUSE University Hospital
  • length of stay in intensive care equal or superior to 24 hours
  • affiliated to a social security system
  • having expressed no objection to participate in the study

You may not qualify if:

  • minor patient
  • no consent to the study
  • patient not capable of expressing his "non opposition" to the study
  • patient under guardianship, curatorship or safeguard of justice

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Toulouse

Toulouse, France

Location

MeSH Terms

Conditions

postintensive care syndrome

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2022

First Posted

September 10, 2022

Study Start

October 10, 2022

Primary Completion

June 30, 2023

Study Completion

June 30, 2023

Last Updated

September 25, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations